{"id":"W1975313529","doi":"10.1016/s1556-0864(15)31641-5","title":"Second-line or Subsequent Systemic Therapy for Recurrent or Progressive Non-Small Cell Lung Cancer: A Systematic Review and Practice Guideline","year":2006,"lang":"en","type":"review","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":false,"ca_institutions":"McMaster University; Hamilton Health Sciences; Cancer Care Ontario; Juravinski Cancer Centre; Sudbury Regional Hospital","funders":"","keywords":"Docetaxel; Medicine; Internal medicine; Erlotinib; Pemetrexed; Oncology; Lung cancer; Gefitinib; Topotecan; Febrile neutropenia; Afatinib; Guideline; Regimen; Vinorelbine; Chemotherapy; Cancer; Neutropenia; Epidermal growth factor receptor; Pathology; Cisplatin","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005069694,0.0009537385,0.005423205,0.003411824,0.0003063792,0.0009143676,0.002016689,0.001551888,0.003162001],"category_scores_gemma":[0.01258145,0.0007390449,0.005527558,0.002785996,0.0003959395,0.001094562,0.0008772798,0.001226648,0.0004956287],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002694619,"about_ca_system_score_gemma":0.006108562,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.008932718,"about_ca_topic_score_gemma":0.05106559,"domain_scores_codex":[0.9968295,0.001010502,0.001263002,0.0002737277,0.0005257762,0.00009745794],"domain_scores_gemma":[0.9924986,0.003247987,0.002719328,0.0001216111,0.001196989,0.0002154247],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0006340505,0.00006510155,0.001927749,0.6182584,0.01443708,0.0003792445,0.0002388175,0.0005295771,0.0008844067,0.0006986225,0.05924666,0.3027003],"study_design_scores_gemma":[0.003630377,0.0007183106,0.01454139,0.6738578,0.1065799,0.001846921,0.0002734294,0.0006268666,0.0009511961,0.001370076,0.1954837,0.0001201187],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00111144,0.9917319,0.0007210575,0.002616867,0.0006518102,0.0008353405,0.001065567,0.00003301879,0.001232989],"genre_scores_gemma":[0.01914911,0.9676996,0.00690464,0.002977175,0.0002586297,0.001117039,0.0008061506,0.00001284715,0.001074786],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.008932718,"threshold_uncertainty_score":0.02681142,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07230581937056216,"score_gpt":0.5353964829965041,"score_spread":0.463090663625942,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}